TITAN PHARMACEUTICALS INC Uncategorized Contracts & Agreements
30 Contracts & Agreements
- Resignation Agreement, dated April 2, 2024, between the Company and Katherine Beebe DeVarney (Filed With SEC on April 3, 2024)
- Agreement, dated April 2, 2024, between the Company and Avraham Ben-Tzvi (Filed With SEC on April 3, 2024)
- Resignation Agreement, dated April 2, 2024, between the Company and David Lazar (Filed With SEC on April 3, 2024)
- Amendment and Extension Agreement between Titan Pharmaceuticals, Inc. and Fedson, Inc., dated as of August 25, 2023 (Filed With SEC on August 30, 2023)
- Agreement for Co-Promotion Partnership, dated June 23, 2020, by and between Titan Pharmaceuticals, Inc. and Indegene, Inc (Filed With SEC on August 14, 2020)
- Amendment to Rights Agreement dated May 16, 2018 (Filed With SEC on May 16, 2018)
- Rights Agreement dated March 21, 2018 (Filed With SEC on March 26, 2018)
- Form of Warrants (Filed With SEC on March 26, 2018)
- CONFIDENTIALTREATMENT REQUESTED. INFORMATIONFOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[*******]” OR OTHERWISE CLEARLY INDICATED. AN... (Filed With SEC on November 13, 2013)
- Braeburn Pharmaceuticals Sprl c/o Apple Tree Partners 51 East 12th Street, 5th Flr. New York, NY 10003 (Filed With SEC on July 5, 2013)
- CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIALTREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH [*******] OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED... (Filed With SEC on May 29, 2013)
- AMENDMENT AGREEMENT (Filed With SEC on February 7, 2013)
- AMENDMENT NO. 2 TO RIGHTS AGREEMENT (Filed With SEC on April 10, 2012)
- Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on April 10, 2012)
- AMENDMENT NO. 1 TO RIGHTS AGREEMENT (Filed With SEC on March 15, 2012)
- PAYING AGENT AGREEMENT (Filed With SEC on November 17, 2011)
- W I T N E S S E T H: (Filed With SEC on November 17, 2011)
- AMENDED AND RESTATED ROYALTY AGREEMENT (Filed With SEC on November 17, 2011)
- EQUITY OPTION AGREEMENT (Filed With SEC on March 18, 2011)
- ROYALTY AGREEMENT (Filed With SEC on March 18, 2011)
- CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF (Filed With SEC on June 2, 2008)
- 400 Oyster Point Blvd., Suite 505, South San Francisco, CA 94080 Tel. (650) 244-4990 Fax(650) 244-4956 (Filed With SEC on April 30, 2008)
- Marc Rubin Chief Executive Officer (Filed With SEC on March 12, 2008)
- /s/ MARCRUBIN (Filed With SEC on March 12, 2008)
- 400 Oyster Point Blvd., Suite 505, South San Francisco, CA 94080 Tel. (650) 244-4990 Fax ###-###-#### (Filed With SEC on November 8, 2007)
- 400 Oyster Point Blvd., Suite 505, South San Francisco, CA 94080 Tel. (650) 244-4990 Fax ###-###-#### (Filed With SEC on November 8, 2007)
- /S/ THOMAS G.PINOU (Filed With SEC on March 16, 2006)
- TITAN PHARMACEUTICALS, INC. PLACEMENT AGENT AGREEMENT (Filed With SEC on September 30, 2005)
- AMENDMENT TO EMPLOYMENTAGREEMENT (Filed With SEC on March 15, 2005)
- TITANPHARMACEUTICALS, INC. 2002STOCK OPTION PLAN (Filed With SEC on March 31, 2003)
